Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-26 | 3 co-filers VP GC & Secretary | Option exercise | 1,154 | $62.34 | $72k |
| 2026-08-26 | 3 co-filers VP GC & Secretary | Tax withholding | 339 | $62.34 | $21k |
| 2026-08-26 | 3 co-filers VP GC & Secretary | Option exercise | 1,154 | $0.00 | — |
| 2026-08-10 | 3 co-filers SVP & Chief Financial Officer | Option exercise | 1,358 | $64.67 | $88k |
| 2026-08-10 |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| Tax withholding |
| 398 |
| $64.67 |
| $26k |
| 2026-08-10 | 3 co-filers SVP & Chief Financial Officer | Option exercise | 1,358 | $0.00 | — |
| 2026-05-11 | 3 co-filers VP and GM Surfactants-INT | Option exercise | 90 | $52.58 | $5k |
| 2026-05-11 | 3 co-filers VP and GM Surfactants-INT | Tax withholding | 50 | $52.58 | $3k |
| 2026-05-11 | 3 co-filers VP and GM Surfactants-INT | Option exercise | 90 | $0.00 | — |
| 2026-05-08 | Painter Corning F. Director | Grant | 2,566 | $52.61 | $135k |
| 2026-05-08 | Stepan F Quinn Jr Director | Grant | 2,566 | $52.61 | $135k |
| 2026-05-08 | Reed Jan Stern Director | Grant | 2,566 | $52.61 | $135k |
| 2026-05-08 | Lewis Susan Director | Grant | 2,566 | $52.61 | $135k |
| 2026-05-08 | Delgado Joaquin Director | Grant | 2,566 | $52.61 | $135k |
| 2026-05-08 | Burgess Lorinda Director | Grant | 2,566 | $52.61 | $135k |
| 2026-05-08 | Dearth Randall S. Director | Grant | 2,566 | $52.61 | $135k |
| 2026-05-01 | 3 co-filers EVP, Supply Chain | Option exercise | 550 | $50.33 | $28k |
| 2026-05-01 | 3 co-filers EVP, Supply Chain | Tax withholding | 162 | $50.33 | $8k |
| 2026-05-01 | 3 co-filers EVP, Supply Chain | Option exercise | 550 | $0.00 | — |
| 2026-04-13 | 3 co-filers VP and GM Surfactants NA | Grant | 1,310 | $0.00 | — |
| 2026-04-13 | 3 co-filers VP and GM Surfactants-INT | Grant | 2,859 | $0.00 | — |
| 2026-04-13 | 3 co-filers VP and GM Surfactants-INT | Grant | 4,030 | $0.00 | — |
| 2026-04-13 | 3 co-filers VP and GM Surfactants NA | Grant | 2,621 | $0.00 | — |
| 2026-04-13 | 3 co-filers VP and GM Surfactants NA | Grant | 3,694 | $0.00 | — |
| 2026-04-13 | 3 co-filers VP and GM Surfactants-INT | Grant | 1,429 | $0.00 | — |
| 2026-03-04 | 6 co-filers VP & GM Surfactants | Tax withholding | 166 | $49.62 | $8k |
| 2026-03-04 | 6 co-filers V.P. and Gen'l. Mgr., Polymers | Tax withholding | 149 | $49.62 | $7k |
| 2026-03-04 | 6 co-filers VP & GM Surfactants | Option exercise | 571 | $49.62 | $28k |
| 2026-03-04 | 6 co-filers V.P. and Gen'l. Mgr., Polymers | Option exercise | 429 | $49.62 | $21k |
| 2026-03-04 | 6 co-filers EVP, Supply Chain | Option exercise | 571 | $49.62 | $28k |
| 2026-03-04 | 6 co-filers President & CEO | Option exercise | 857 | $49.62 | $43k |
| 2026-03-04 | 6 co-filers EVP, Supply Chain | Tax withholding | 168 | $49.62 | $8k |
| 2026-03-04 | 6 co-filers President & CEO | Tax withholding | 252 | $49.62 | $13k |
| 2026-03-04 | 6 co-filers V.P. and Gen'l. Mgr., Polymers | Option exercise | 429 | $0.00 | — |
| 2026-03-04 | 6 co-filers VP & GM Surfactants | Option exercise | 571 | $0.00 | — |
| 2026-03-04 | 6 co-filers President & CEO | Option exercise | 857 | $0.00 | — |
| 2026-03-04 | 6 co-filers EVP, Supply Chain | Option exercise | 571 | $0.00 | — |
| 2026-03-03 | 6 co-filers President & CEO | Option exercise | 4,455 | $48.98 | $218k |
| 2026-03-03 | 6 co-filers EVP, Supply Chain | Option exercise | 1,670 | $48.98 | $82k |
| 2026-03-03 | 6 co-filers President & CEO | Tax withholding | 1,306 | $48.98 | $64k |
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 13 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PG | $372.2B | 24.3× | 17.7× | 4.3× | 3.3% | 50.2% | 18.4% | 29.5% | 18.1% | 1.5× | 1,518 |
| ECL | $84.3B | 41.3× | 27.0× | 5.2× | 2.2% | 44.5% | 12.9% | 21.2% | 11.5% | 2.2× | 541 |
| CL | $74.3B | 35.4× | 20.6× | 3.6× | 1.4% | 60.1% | 10.5% | — | 26.5% | 1.7× | 646 |
| EL | $39.4B | 217.6× | 25.3× | 2.6× | 5.0% | 75.5% | 1.2% | 4.8% | 4.2% | 0.3× | 224 |
| KVUE | $37.6B | 25.7× | 12.8× | 2.5× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.1× | 257 |
| CHD | $25.1B | 35.1× | 20.3× | 4.0× | 1.6% | 44.7% | 11.9% | 18.4% | 11.9% | 1.4× | 287 |
| CLX | $10.7B | 13.6× | — | 1.5× | 0.2% | 45.2% | 11.4% | 252% | 28.9% | — | 312 |
| ELF | $6.7B | 256.7× | 47.4× | 4.1× | 24.6% | 70.7% | 1.6% | 2.3% | 1.3% | 3.8× | 102 |
| IPAR | $3.7B | 22.0× | 12.9× | 2.5× | 2.5% | 63.6% | 11.3% | 19.1% | 16.6% | 0.4× | 61 |
| COTY | $3.0B | — | 14.5× | 0.5× | -1.5% | 62.9% | -10.4% | -20.2% | -10.0% | 7.2× | 62 |
| SCL | $1.6B | 34.1× | 10.2× | 0.7× | 7.0% | 11.6% | 2.0% | 3.8% | 2.5% | 2.4× | 49 |
| EPC | $1.3B | 53.9× | 14.6× | 0.6× | -1.3% | 41.6% | 1.1% | 1.6% | 0.9% | 7.5× | 48 |
| ODD | $1.0B | 12.1× | 4.6× | 1.2× | 25.2% | 72.7% | 13.7% | 27.9% | 27.9% | -3.1× | 25 |
| WALD | $108M | — | — | 0.4× | -0.7% | 67.3% | -84.4% | -49.7% | -38.4% | — | — |
Peers = companies sharing SCL's sector (Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 2 positive fiscal years (FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $69.99 today, the market must believe free cash flow compounds 23.3%/yr for a decade (off $32.3M on the 3-yr avg basis).
On the basis ($26.6M) the requirement is 26.0%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 23.3% is more optimistic than its 9-yr track record.
Default is 9.8% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.02B shares (market data) · net debt $494.0M
mean -39.4% · volatility σ 88% · implied rate exceeded in 1/6 yrs
Central path = implied 23.3%/yr growth; shaded band = ±1σ (88%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
What the company returns to shareholders — and whether it's covered by cash.
The dividend exceeds free cash flow (138%) — funded from the balance sheet or debt, a red flag if it persists. Last year: $35.0M dividends + $0 buybacks = $35.0M returned on $25.4M FCF.
9 consecutive years of dividend increases · 8%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 3%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-29
Where each multiple sits in its own 14-yr range · 57th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 4% against ROIC 3% — 1% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.6× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 83.0 | 81.7 | 79.5 | 83.1 | 84.6 | 88.1 | 87.5 | 88.4 |
| Gross Profit | 17.0 | 18.3 | 20.5 | 16.9 | 15.4 | 11.9 | 12.5 | 11.6 |
| R&D | 1.7 | 1.8 | 1.9 | 1.7 | 1.5 | 1.5 | 1.5 | 1.5 |
| SG&A | 4.0 | 4.4 | 4.7 | 4.0 | 3.7 | 4.0 | 4.5 | 3.9 |
| Operating Income | 7.5 | 6.8 | 9.2 | 7.3 | 7.5 | 2.5 | 3.2 | 3.4 |
| Income Tax | 1.3 | 1.2 | 2.3 | 1.5 | 1.5 | 0.4 | 0.5 | 0.6 |
| Net Income | 5.6 | 5.5 | 6.8 | 5.9 | 5.3 | 1.7 | 2.3 | 2.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on SCL: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $132.7M is below the $285.7M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~4.9% on $626.7M of debt.
Cash of $132.7M is below short-term debt of $285.7M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Earns -6.39pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 11.9% | 9.8% (today's — no rate published for this year) | 2.1pts |
| FY2020 | 15.0% | 9.8% (today's — no rate published for this year) | 5.1pts |
| FY2021 | 10.0% | 4.8% | 5.2pts |
| FY2022 | 10.0% | 7.4% | 2.6pts |
| FY2023 | 2.6% | 8.5% | -5.9pts |
| FY2024 | 3.2% | 9.9% | -6.7pts |
| FY2025 | 3.5% | 9.4% | -6.0pts |
| Now | 2.5% | 9.8% | -7.3pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 19.2% | 7.2% | 4.9% |
| FY2017 | 18.0% | 8.0% | 5.2% |
| FY2018 | 17.0% | 7.5% | 5.6% |
| FY2019 | 18.3% | 6.8% | 5.5% |
| FY2020 | 20.5% | 9.2% | 6.8% |
| FY2021 | 16.9% | 7.3% | 5.9% |
| FY2022 | 15.4% | 7.5% | 5.3% |
| FY2023 | 11.9% | 2.5% | 1.7% |
| FY2024 | 12.5% | 3.2% | 2.3% |
| FY2025 | 11.6% | 3.4% | 2.0% |
Return on equity (4%) and return on invested capital (3%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
$92M of goodwill — 5% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer.
Net margin is 201.08% against 530.61% 3 years ago — a step down the business has not recovered, whatever the spread says today.
Cash conversion of -0.53x sits below the level that would make the earnings clearly cash-backed.
Reported free cash flow is $25M; after share-based compensation it is $19M. The difference is a real cost that the cash flow statement adds back.
Stressed coverage of 1.8x sits between comfortable and thin.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 2.55x |
| 5% | 2.42x |
| 10% | 2.30x |
| 15% | 2.17x |
| 20% | 2.04x |
| 25% | 1.91x |
| 30% | 1.79x |
| 35% | 1.66x |
| 40% | 1.53x |
| 45% | 1.40x |
| 50% | 1.28x |
| 55% | 1.15x |
| 60% | 1.02x |
Ladder as of 2025-12-31 (10-K); cash from the 2025-12-31 balance sheet; FCF from FY2025.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $69.99, free cash flow must compound 23.72%/yr for 10 years. It has done -22.02%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | −3.0% | 23.7% |
| FY2021 | −211.8% | 23.7% |
| FY2025 | −35.4% | 23.7% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM (share count from the last fiscal year — the TTM window reports none).
The implied rate of 23.72% has not been achieved in any of the last 3 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $47M | $47M |
| Share-based comp | $6M | $53M |
| Other non-cash & working capital | $95M | $148M |
| Operating cash flow | $148M | $148M |
| Capex | −$123M | $25M |
| Free cash flow | $25M | $25M |
| FCF after SBC | $19M | $19M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 0.6% | not reported | not reported |
| FY2021 | 25.5% | not reported | not reported |
| FY2022 | 18.2% | not reported | not reported |
| FY2023 | -16.1% | not reported | not reported |
| FY2024 | -6.3% | not reported | not reported |
| FY2025 | 7.0% | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -7.3 percent |
| FY2020 | -6.2 percent |
| FY2021 | 3.2 percent |
| FY2022 | -0.6 percent |
| FY2023 | -5.7 percent |
| FY2024 | -4.8 percent |
| FY2025 | -4.3 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 1 year to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
EOD close · as of 2026-10-29
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.33B 100.0% | $2.18B 100.0% | $2.33B 100.0% | $2.77B 100.0% | $2.35B 100.0% | $1.87B 100.0% | $1.86B 100.0% | $1.99B 100.0% | $1.93B 100.0% | $1.77B 100.0% |
| Cost of Revenue | $2.06B 88.4% | $1.91B 87.5% | $2.05B 88.1% | $2.35B 84.6% | $1.95B 83.1% | $1.49B 79.5% | $1.52B 81.7% | $1.65B 83.0% | $1.58B 82.0% | $1.43B 80.8% |
| Gross Profit | $269.9M 11.6% | $272.2M 12.5% | $277.6M 11.9% | $427.1M 15.4% | $395.8M 16.9% | $383.6M 20.5% | $339.7M 18.3% | $339.3M 17.0% | $346.2M 18.0% | $339.3M 19.2% |
| Research & Development | $34.8M 1.5% | $33.5M 1.5% | $35.7M 1.5% | $40.9M 1.5% | $38.8M 1.7% | $36.0M 1.9% | $34.1M 1.8% | $33.5M 1.7% | $33.2M 1.7% | $34.9M 2.0% |
| Selling, General & Admin | $90.8M 3.9% | $98.3M 4.5% | $93.2M 4.0% | $102.2M 3.7% | $92.9M 4.0% | $87.4M 4.7% | $82.6M 4.4% | $79.2M 4.0% | $75.6M 3.9% | $74.9M 4.2% |
| Total Operating Expenses | $201.0M 8.6% | $201.7M 9.3% | $205.0M 8.8% | $218.4M 7.9% | $221.7M 9.4% | $210.9M 11.3% | $209.7M 11.3% | $187.5M 9.4% | $188.3M 9.8% | $204.4M 11.6% |
| Operating Income | $78.5M 3.4% | $70.5M 3.2% | $58.6M 2.5% | $207.3M 7.5% | $170.8M 7.3% | $171.5M 9.2% | $127.3M 6.8% | $149.3M 7.5% | $154.8M 8.0% | $127.8M 7.2% |
| Interest Expense | $30.8M 1.3% | $33.0M 1.5% | $29.4M 1.3% | $17.9M 0.6% | $10.1M 0.4% | $9.9M 0.5% | $12.7M 0.7% | $13.4M 0.7% | $14.4M 0.7% | — |
| Interest & Investment Income | $4.1M 0.2% | $5.3M 0.2% | $3.8M 0.2% | $1.1M 0.0% | $1.3M 0.1% | $2.2M 0.1% | $5.7M 0.3% | $1.8M 0.1% | $2.1M 0.1% | $1.2M 0.1% |
| Other Income (Expense), net | -$18.6M -0.8% | -$10.0M -0.5% | -$10.2M -0.4% | -$18.6M -0.7% | $1.8M 0.1% | -$455K -0.0% | -$1.4M -0.1% | -$11.5M -0.6% | -$8.0M -0.4% | -$14.0M -0.8% |
| Pretax Income | $59.9M 2.6% | $60.4M 2.8% | $48.4M 2.1% | $188.7M 6.8% | $172.5M 7.4% | $171.1M 9.1% | $125.9M 6.8% | $137.8M 6.9% | $146.9M 7.6% | $113.8M 6.4% |
| Income Tax Expense | $13.0M 0.6% | $10.1M 0.5% | $8.2M 0.4% | $41.5M 1.5% | $34.6M 1.5% | $43.4M 2.3% | $22.8M 1.2% | $26.7M 1.3% | $46.1M 2.4% | $27.6M 1.6% |
| Net Income | $46.9M 2.0% | $50.4M 2.3% | $40.2M 1.7% | $147.2M 5.3% | $137.8M 5.9% | $126.8M 6.8% | $103.1M 5.5% | $111.1M 5.6% | $100.8M 5.2% | $86.2M 4.9% |
| Per Share | ||||||||||
| EPS (Basic) | $2.05 | $2.21 | $1.77 | $6.46 | $6.01 | $5.52 | $4.47 | $4.83 | $4.39 | $3.78 |
| EPS (Diluted) | $2.05 | $2.20 | $1.75 | $6.38 | $5.92 | $5.45 | $4.42 | $4.76 | $4.31 | $3.73 |
| Weighted Avg Shares (Basic) | 22.9M | 22.8M | 22.8M | 22.8M | 22.9M | 22.9M | 23.1M | 23.0M | 22.9M | 22.8M |
| Weighted Avg Shares (Diluted) | 22.9M | 22.9M | 22.9M | 23.1M | 23.3M | 23.3M | 23.3M | 23.3M | 23.4M | 23.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.